Saturday, September 29, 2018

Sloan Kettering Executive Turns Over Windfall Stake in Biotech Start-Up

Source: https://www.nytimes.com/2018/09/29/health/memorial-sloan-kettering-cancer-biotech-ethics.html?partner=rss&emc=rss
September 29, 2018 at 07:15PM

With the cancer center’s corporate ties under scrutiny, the hospital told employees that no one should profit personally from representing MSK on outside boards.

No comments:

Post a Comment

Blog Archive